Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8081 - 8088 of 12008 results
International Deals Pose Unique Risks
June 13, 2016| News
DOJ and NC File Antitrust Suit Challenging Anti-Steering Restrictions in Payor Contracts
June 10, 2016| Alert| Viewpoint
Anti-Steering Restrictions in Payor Contracts Face Antitrust Challenge by DOJ and NC
June 10, 2016| Blog| Viewpoint
End Isn't Nigh For FCC Rules On Local TV Station Deals
June 10, 2016| News
Federal Court Declines to Exercise Jurisdiction Over Toshiba Despite Over-the-Counter ADS Sales in the United States
June 9, 2016| Blog| Viewpoint
Legislation to Reduce Consumer Cost-Sharing Takes a Back Burner in the Drug Pricing Debate
June 9, 2016| Blog| Viewpoint
Employers, Join Us for a Webinar: The New White-Collar Overtime Rule
June 9, 2016| Blog| Viewpoint
Tackling the Dragon of Hospital Price Disparity: Massachusetts's On-Going Efforts to Address Price Equity
June 8, 2016| Alert| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|